Profile
Mr. Christian Schütte is on the Board of Directors at VERTILAS GmbH and Elcos AG.
Mr. Schütte was previously employed as a Director-Supervisory Board by Cor Pumps + Compressors AG and a Managing Director by High Tech Private Equity GmbH.
Christian Schütte active positions
| Companies | Position | Start |
|---|---|---|
Elcos AG
Elcos AG Electronic Production EquipmentElectronic Technology Develops and manufactures optoelectronic products | Director/Board Member | - |
Former positions of Christian Schütte
| Companies | Position | End |
|---|---|---|
Cor Pumps + Compressors AG
Cor Pumps + Compressors AG Industrial MachineryProducer Manufacturing Develops and markets pumps and compressors | Director/Board Member | - |
High Tech Private Equity GmbH
High Tech Private Equity GmbH Investment ManagersFinance HTPE is a hands-on manager which takes majority and minority stakes in technology oriented companies in the following sectors: microelectronics, nanotechnology, sensor technology, microsystem technology, optics, optoelectronics, innovative engineering technology and robotics, life sciences, biotech and pharmaceuticals, medical technology and other high-tech sectors (excluding internet and software). They invest in all countries, and in particular in Austria, Canada, Germany, Switzerland, the US and Western Europe. For companies in the expansion phase, the firm typically seeks to invest EUR 2-5 million in companies with developed technology, marketable products, initial revenues with high development potential and management with high technological competence, a strong marketing orientation and a clear strategy. For established mittelstand companies, HTPE seeks to invest EUR 3-10 million in businesses with a turnover of EUR 20-25 million, an established, well structured market position, above-average growth potential for the sector and a management team with a high level of market expertise, a strategic way of thinking and the vision to become a market leader. The firm generally invests EUR 5-10 million in pharmaceutical and biotech companies developing new chemical/biological entities or new products and will only invest in new drug delivery technologies in combination with concrete product development. Their investment criteria include the therapeutic indication, its associated market potential and the availability of a valid patent or patent portfolio. HTPE's investment committee makes the firm's investment decisions. | Chief Investment Officer | 29/12/2009 |
VERTILAS GmbH
VERTILAS GmbH Electronic Equipment/InstrumentsElectronic Technology Develops, produces, and distributes laser diodes for optical communications technology, sensor engineering and measurement methods | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Elcos AG
Elcos AG Electronic Production EquipmentElectronic Technology Develops and manufactures optoelectronic products | Electronic Technology |
High Tech Private Equity GmbH
High Tech Private Equity GmbH Investment ManagersFinance HTPE is a hands-on manager which takes majority and minority stakes in technology oriented companies in the following sectors: microelectronics, nanotechnology, sensor technology, microsystem technology, optics, optoelectronics, innovative engineering technology and robotics, life sciences, biotech and pharmaceuticals, medical technology and other high-tech sectors (excluding internet and software). They invest in all countries, and in particular in Austria, Canada, Germany, Switzerland, the US and Western Europe. For companies in the expansion phase, the firm typically seeks to invest EUR 2-5 million in companies with developed technology, marketable products, initial revenues with high development potential and management with high technological competence, a strong marketing orientation and a clear strategy. For established mittelstand companies, HTPE seeks to invest EUR 3-10 million in businesses with a turnover of EUR 20-25 million, an established, well structured market position, above-average growth potential for the sector and a management team with a high level of market expertise, a strategic way of thinking and the vision to become a market leader. The firm generally invests EUR 5-10 million in pharmaceutical and biotech companies developing new chemical/biological entities or new products and will only invest in new drug delivery technologies in combination with concrete product development. Their investment criteria include the therapeutic indication, its associated market potential and the availability of a valid patent or patent portfolio. HTPE's investment committee makes the firm's investment decisions. | Finance |
VERTILAS GmbH
VERTILAS GmbH Electronic Equipment/InstrumentsElectronic Technology Develops, produces, and distributes laser diodes for optical communications technology, sensor engineering and measurement methods | Electronic Technology |
Cor Pumps + Compressors AG
Cor Pumps + Compressors AG Industrial MachineryProducer Manufacturing Develops and markets pumps and compressors | Producer Manufacturing |
- Stock Market
- Insiders
- Christian Schütte
















